<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00463294</url>
  </required_header>
  <id_info>
    <org_study_id>PHRI-065</org_study_id>
    <nct_id>NCT00463294</nct_id>
  </id_info>
  <brief_title>Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study</brief_title>
  <acronym>CORONARY</acronym>
  <official_title>CABG Off or On Pump Revascularization Study (CORONARY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Dante Pazzanese de Cardiologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fu Wai Hospital, Beijing, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidad de La Frontera</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación Cardiovascular de Colombia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Jean Minjoz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre for Chronic Disease Control, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Santa Croce-Carle Cuneo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hotel Dieu Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SAL Hospital, Ahmedabad, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      I. Main Research Question:&#xD;
&#xD;
        -  To compare the risks and benefits of Off-pump Coronary artery bypass surgery (CABG) to&#xD;
           On-pump CABG and to determine if one is better than the other.&#xD;
&#xD;
        -  The purpose of this pilot study is also to see the rate of recruitment with&#xD;
           expertise-based randomization across different hospital settings.&#xD;
&#xD;
      II. Small RCT studies and meta-analyses done so far have not been able to conclusively say&#xD;
      which of the procedure is better. A large randomized study is required to establish the risks&#xD;
      and benefits associated with both the off-pump and on-pump CABG surgical procedures.&#xD;
&#xD;
      III. The study will look at which of the two techniques reduce major risks associated with&#xD;
      CABG.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale and purpose of the study:&#xD;
&#xD;
      Coronary artery bypass grafting (CABG) surgery prolongs life-expectancy in patients with&#xD;
      severe ischemic heart disease, especially those with left main, triple vessel disease or&#xD;
      single/double vessel disease with stenosis of the proximal left anterior descending (LAD)&#xD;
      artery. The perioperative mortality is about 2% with an additional 5% to 7% suffering&#xD;
      complications such as myocardial infarction, stroke, renal failure, etc. The technique of&#xD;
      operating on a beating heart (off-pump) for coronary artery bypass grafting surgery has been&#xD;
      recently developed in the past few years in an effort to decrease the above perioperative&#xD;
      complications typically related to cardiopulmonary bypass associated with on-pump CABG. While&#xD;
      registries suggest that off-pump CABG may be superior, these data cannot fully control for&#xD;
      differences in patient characteristics, which influence patient selection for specific&#xD;
      procedures. The benefits of off-pump CABG compared with conventional on-pump CABG are&#xD;
      unclear. The investigators therefore propose a large simple, international multicentre&#xD;
      randomized controlled trial to definitively evaluate the efficacy and safety of off-pump CABG&#xD;
      in the treatment of patients undergoing coronary artery surgery funded by CIHR, this pilot&#xD;
      study will be a preliminary step towards a full trial.&#xD;
&#xD;
      Sample size:&#xD;
&#xD;
      The investigators examined the outcomes in the Canadian off-pump CABG Registry to identify a&#xD;
      group of patients who represent a higher risk of cardiovascular events. Utilizing the&#xD;
      inclusion criteria described below, this group of patients has accumulated the vast majority&#xD;
      of outcomes in the Registry and represent more than 50% of patients in the Registry,&#xD;
      therefore minimizing the sample size but still being representative. The cumulative event&#xD;
      rate at 30 days (first co-primary outcome) for on-pump CABG is estimated as being 8.6% and&#xD;
      the investigators expect a 33% relative risk reduction (RRR) for the off-pump CABG group. The&#xD;
      sample calculated for the whole trial is 4700 patients.&#xD;
&#xD;
      Design/Methodology:&#xD;
&#xD;
      Trial design: This is a pilot randomized controlled trial comparing off-pump CABG versus&#xD;
      on-pump CABG in 60 patients who will be undergoing isolated CABG.&#xD;
&#xD;
      Interventions: Patients eligible for CABG will be randomized to receive either an Off-pump&#xD;
      CABG surgery or On-pump CABG surgery.&#xD;
&#xD;
      Randomization: After obtaining informed written consent patients will be allocated to either&#xD;
      off-pump CABG or on-pump CABG by calling a 24-hour randomization telephone number. An&#xD;
      expertise-based randomization will be used wherein a surgeon who is an expert in Off-pump&#xD;
      surgery will operate on patients randomized to receive Off-pump surgery. Patients randomized&#xD;
      to receive On-pump CABG will be operated on by a surgeon who is an expert in on-pump CABG&#xD;
      surgery. To minimize bias stratified block randomization will used. For this pilot study&#xD;
      randomization will be stratified to 3 centres and random block of 4 or 6.&#xD;
&#xD;
      The data adjudicators will be blinded to the study. Due to the nature of intervention, the&#xD;
      operating surgeon, anesthetist, perfusionist, other operation room staff, intensive-care unit&#xD;
      staff will not be blinded in this study.&#xD;
&#xD;
      Setting:&#xD;
&#xD;
      Patients will have either been seen in the emergency, outpatient or ICU and diagnosed with&#xD;
      having single, double or triple coronary artery occlusion requiring an isolated CABG.&#xD;
&#xD;
      Study interventions:&#xD;
&#xD;
      Interventions: Patients eligible for CABG will be randomized to receive either an Off-pump&#xD;
      CABG surgery or On-pump CABG surgery. A surgeon who is an expert in the assigned technique&#xD;
      will perform the procedure.&#xD;
&#xD;
      Primary outcomes:&#xD;
&#xD;
        -  The occurrence of the composite of total mortality, stroke, nonfatal MI, or new renal&#xD;
           failure at 30 days post CABG surgery AND&#xD;
&#xD;
        -  The occurrence of the composite of total mortality, stroke, nonfatal MI, new renal&#xD;
           failure, or repeat coronary revascularization (i.e. coronary artery bypass surgery or&#xD;
           percutaneous coronary intervention) over 5 years after randomization.&#xD;
&#xD;
      The secondary outcomes&#xD;
&#xD;
        -  The assessment of total costs and resources consumption at 30 days after CABG surgery&#xD;
           AND&#xD;
&#xD;
        -  The assessment of total costs and resources consumption at 5 years after CABG surgery&#xD;
&#xD;
      Measurements:&#xD;
&#xD;
      The investigators will ascertain all events of interest through periodic and regular&#xD;
      follow-up utilizing standardized definitions for all events, appropriate supporting documents&#xD;
      will be obtained centrally.&#xD;
&#xD;
        -  CV death: all deaths are considered cardiovascular unless a specific non-cardiovascular&#xD;
           cause is evident (e.g. malignancy).&#xD;
&#xD;
        -  Stroke: new acute focal neurological deficit (except for subarachnoid hemorrhage which&#xD;
           may not be focal) thought to be of vascular origin with signs or symptoms lasting&#xD;
           greater than 24 hours.&#xD;
&#xD;
        -  MI perioperative (within 24 hours of surgery): new pathologic Q waves with documented&#xD;
           new wall motion abnormalities other than septal OR cardiac markers ³ 10 x ULN.&#xD;
&#xD;
        -  MI non-perioperative (later than 24 hours after surgery): ECG changes consistent with&#xD;
           infarction (new significant Q waves in two contiguous leads in the absence of previous&#xD;
           LVH or conduction abnormalities) or evolving ST-segment to T-wave changes in two&#xD;
           contiguous leads or new left bundle branch block or ST segment elevation requiring&#xD;
           thrombolysis or PCI AND cardiac markers (troponins or CKMB) in the necrosis range.&#xD;
           Post-PCI MI are included into non-perioperative MI group but are defined as new&#xD;
           pathologic Q waves with documented new wall motion abnormalities other than septal OR&#xD;
           cardiac markers ³ 3 x ULN within 24 hours of PCI.&#xD;
&#xD;
        -  Renal failure: doubling of serum creatinine from pre-op baseline or requirement for&#xD;
           renal replacement therapy (eg, dialysis, continuous hemofiltration, renal transplant).&#xD;
           Hemofiltration or dialysis only during cardio-pulmonary bypass does not constitute a&#xD;
           requirement for renal replacement therapy. Patients who receive dialysis within 1 month&#xD;
           of the surgery are not eligible for this endpoint.&#xD;
&#xD;
        -  Repeated coronary revascularization: new CABG procedure or PCI associated with&#xD;
           documented ischemia by stress testing (ECG, ECHO, or nuclear) AND graft failure or new&#xD;
           culprit lesion (³ 70% luminal stenosis).&#xD;
&#xD;
      For other endpoints, the investigators have defined:&#xD;
&#xD;
        -  Recurrence of angina: new or chronic onset of typical chest pain with documented&#xD;
           ischemia by stress testing (ECG, ECHO, or nuclear).&#xD;
&#xD;
        -  Blood transfusions: all blood bank products transfused within 24 hours of the CABG&#xD;
           surgery.&#xD;
&#xD;
        -  Total mortality: all causes of mortality&#xD;
&#xD;
      Plan for data analysis:&#xD;
&#xD;
      The intention to treat principle, in which all participants will be included in their&#xD;
      assigned treatment groups regardless of adherence, will guide all analyses. In the principle&#xD;
      analysis, the time to the first occurrence of one of the components of the cluster of&#xD;
      (cardiac death, stroke, nonfatal MI, new renal failure) will be presented by Kaplan-Meier&#xD;
      survival curves and the comparisons between the two treatment groups will be performed by a&#xD;
      log-rank test. The treatment effect as measured by the hazard ratio and 95% confidence&#xD;
      interval will be derived by the Cox proportional hazards model. The investigators will also&#xD;
      calculate the absolute risk reductions and the associated 95% confidence intervals, as well&#xD;
      as the number needed to treat (NNT) with off-pump CABG to prevent one major cardiovascular&#xD;
      event. Participants who prematurely discontinue follow-up before a major cardiovascular event&#xD;
      will be censored as to their last follow-up data; this number is expected to be &lt;1% given the&#xD;
      relatively short period of follow-up after surgery.&#xD;
&#xD;
      In secondary analyses the investigators will determine and compare the incidence of major&#xD;
      cardiovascular events (cardiac death, stroke, nonfatal MI, new renal dialysis) and&#xD;
      revascularization procedures (i.e. coronary artery bypass surgery and percutaneous coronary&#xD;
      intervention) using the same strategy. The effect of the two operative techniques on&#xD;
      different sub-groups (i.e. patients with diabetes, renal failure, congestive heart failure,&#xD;
      cerebrovascular disease, as well as patient left ventricular function, gender and ages will&#xD;
      be conducted by stratified analysis through a Cox proportional hazards model. The test of&#xD;
      interaction between each subgroup factor and the treatment group will be done by including a&#xD;
      product term in the model already containing treatment and the subgroup factor. The length of&#xD;
      hospital stay and length of ICU/CCU stay will be compared using a student's t-test. An events&#xD;
      adjudication committee (blind to surgical allocation) will centrally review all suspected&#xD;
      major outcomes listed above.&#xD;
&#xD;
      The investigators will also do subgroup analysis on different sub-groups (i.e. patients with&#xD;
      diabetes, renal failure, congestive heart failure, cerebrovascular disease, as well as&#xD;
      patient left ventricular function, gender and ages will be examined for consistency and&#xD;
      coherence)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Co-Primary Outcome</measure>
    <time_frame>30 days post CABG surgery</time_frame>
    <description>The occurrence of the composite of total mortality, stroke, nonfatal MI, or new renal failure at 30 days post CABG surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Second co-primary outcome</measure>
    <time_frame>5 years after CABG</time_frame>
    <description>The occurrence of the composite of total mortality, stroke, nonfatal MI, new renal failure, or repeat coronary revascularization (i.e. coronary artery bypass surgery or percutaneous coronary intervention) over 5 years after randomization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The assessment of total costs and resources consumption at 30 days after CABG surgery</measure>
    <time_frame>30 days after CABG surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The assessment of total costs and resources consumption at 5 years after CABG surgery</measure>
    <time_frame>5 years after CABG surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4752</enrollment>
  <condition>the Efficacy and Safety of Off-pump CABG</condition>
  <arm_group>
    <arm_group_label>On Pump Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Off Pump Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary Artery Bypass Graft with the use of CPB</intervention_name>
    <description>Coronary Artery Bypass Graft (CABG) using median sternotomy, CPB, cardioplegia and complete cross-clamp and no associated or concomitant surgical procedures</description>
    <arm_group_label>On Pump Arm</arm_group_label>
    <other_name>ON Pump CABG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary Artery Bypass Graft without the use of CPB</intervention_name>
    <description>Coronary Artery Bypass Graft (CABG) with no associated or concomitant surgical procedures, using median sternotomy and without CPB and cardioplegia</description>
    <arm_group_label>Off Pump Arm</arm_group_label>
    <other_name>OFF Pump</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients who have been diagnosed with coronary artery disease (single, double or triple&#xD;
        disease) will be eligible if they:&#xD;
&#xD;
          1. require isolated CABG with median sternotomy&#xD;
&#xD;
          2. are able to give their informed written consent&#xD;
&#xD;
          3. are&gt; 21 years of age and&#xD;
&#xD;
          4. have one or more of the following risk factors:&#xD;
&#xD;
               -  ≥ 70 years&#xD;
&#xD;
               -  peripheral vascular disease (previous peripheral bypass or amputation or ABI&#xD;
                  &lt;0.80)&#xD;
&#xD;
               -  Cerebrovascular disease (history of stroke, TIA)&#xD;
&#xD;
               -  Renal insufficiency (creatinine above upper limit of normal)&#xD;
&#xD;
               -  &gt;60 years of age and one of the following:&#xD;
&#xD;
                    -  diabetes (oral hypoglycemic agent and/or insulin)&#xD;
&#xD;
                    -  urgent revascularization (waiting in hospital)&#xD;
&#xD;
                    -  LV ejection fraction &lt;35%&#xD;
&#xD;
                    -  current or recent smoker.&#xD;
&#xD;
               -  55-59 years of age and two of the following:&#xD;
&#xD;
                    -  diabetes (oral hypoglycemic agent and/or insulin)&#xD;
&#xD;
                    -  urgent revascularization (waiting in hospital)&#xD;
&#xD;
                    -  LV ejection fraction &lt;35%&#xD;
&#xD;
                    -  current or recent smoker.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients will be excluded if they have one of the following:&#xD;
&#xD;
          1. concomitant cardiac procedure associated with CABG,&#xD;
&#xD;
          2. contra-indications to off-pump CABG or on-pump CABG (calcified aorta, intramuscular&#xD;
             LAD, calcified coronaries, small target vessels)&#xD;
&#xD;
          3. concomitant life-threatening disease likely to limit life expectancy to less than 2&#xD;
             years,&#xD;
&#xD;
          4. prior enrollment in this trial&#xD;
&#xD;
          5. emergency CABG surgery (immediate revascularization for hemodynamic instability) OR&#xD;
&#xD;
          6. redo CABG.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lamy Andre, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salim Yusuf, MD, DPhil</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Taggart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fundacion Medica de rio negro y neuquen</name>
      <address>
        <city>Rio Negro</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beneficencia Portuguesa de Sao Paulo</name>
      <address>
        <city>Sao Paulo,</city>
        <state>CEP</state>
        <zip>01323.001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese de Cardiologia</name>
      <address>
        <city>Sao Paulo</city>
        <state>CEP</state>
        <zip>04012-909</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sao Francisco Complexo Hospitalar Santa Casa</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90020-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Irmande Santa Casa De Misericordia De Curtiba</name>
      <address>
        <city>Curitiba Parana</city>
        <zip>80010030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Braile Clinica de Servicos de Assistencia Medico</name>
      <address>
        <city>Sao Jose do Rio Preto</city>
        <zip>15091-450</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Irmandade da Santa Casa de Misericordia de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01221-020</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal University of Sao Paulo School of Medicine</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04024-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto do Coracao do Hospital das Clinicas da</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-00</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Mario Covas</name>
      <address>
        <city>Sao Paulo</city>
        <zip>09190-615</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericordia de Marilia</name>
      <address>
        <city>Sao Paulo</city>
        <zip>17515-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associação do Sanátorio Sírio</name>
      <address>
        <city>São Paulo</city>
        <zip>04038-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hotel-Dieu du CHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Temuco</name>
      <address>
        <city>Temuco</city>
        <state>IX Region</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional del Torax</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ChaoYang Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FuWai Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing First Hospital</name>
      <address>
        <city>Nanjing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Cardioinfantil</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Valle Del Lili</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charles University Hospital</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiochirurgicke centrum</name>
      <address>
        <city>Ostrava-Poruba</city>
        <zip>708 52</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Pilsen</name>
      <address>
        <city>Pilsen</city>
        <zip>304 60</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Kralovske Vinohrady (FNKV)</name>
      <address>
        <city>Prague</city>
        <zip>100 34</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Motol</name>
      <address>
        <city>Praha</city>
        <zip>150 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemocnice Podlesi</name>
      <address>
        <city>Trinec</city>
        <zip>739 61</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de chirurgie thoracique et cardio-vasculaire</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nizam's Institute of Medical Sciences</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500 082</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SAL Hospital and Medical Institute</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amrita Institute of Medical Sciences and Research Center</name>
      <address>
        <city>Cochin</city>
        <state>Kerala</state>
        <zip>682 026</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G.Kuppuswamy Naidu Memorial Hospital</name>
      <address>
        <city>Coimbatore</city>
        <state>TamilNadu</state>
        <zip>641 037</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SAL Hospital</name>
      <address>
        <city>Ahmedabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>International Center of Cardiovascular and Thoracic Diseases</name>
      <address>
        <city>Chennai Tamil Nadu</city>
        <zip>600101</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanjay Gandhi PGIMS</name>
      <address>
        <city>Lucknow</city>
        <zip>226 014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <zip>110016</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Escorts Heart Institute and Research Centre</name>
      <address>
        <city>Noida</city>
        <zip>201307</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Croce</name>
      <address>
        <city>Cuneo</city>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Niguarda - Ca Granda</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jagiellonian University</name>
      <address>
        <city>Krakow</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alp Aslan</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erol Senor</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruchan Akar</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sertap Aykut Aka</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Volkan Sinci</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Basildon and Thurrock University Hospital NHS FT</name>
      <address>
        <city>Basildon</city>
        <state>Essex</state>
        <zip>SS16 5NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <state>EU</state>
        <zip>16 4SU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>India</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>April 18, 2007</study_first_submitted>
  <study_first_submitted_qc>April 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2007</study_first_posted>
  <last_update_submitted>September 15, 2016</last_update_submitted>
  <last_update_submitted_qc>September 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Population Health Research Institute</investigator_affiliation>
    <investigator_full_name>Andre Lamy</investigator_full_name>
    <investigator_title>Cardiac Surgeon</investigator_title>
  </responsible_party>
  <keyword>CABG</keyword>
  <keyword>On-pump</keyword>
  <keyword>Off-pump</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

